The study, also supported by Perceptive iCRO, demonstrates novel neural mechanism associated with drug effect at 52 weeks.
Read more here.
Best Abstract Award at the European Association for the Study of Diabetes 2026: Cagrisema trial results presented by Novo Nordisk highlight Ceretype fMRI work
by
Tags: